HomeAbout UsProjectsPublicationsStaffContact UsLinks

 


 

 

 

 

 

The University of Alabama at Birmingham Home Page


 


Why is global TB control essential in the 21st century?

The World Health Organization (WHO) declared the TB epidemic a global emergency in 1993.  Each year, approximately 1.5 million people die of TB, and 8 million new cases occur. Drug resistance is a growing problem; WHO has reported that up to 50 percent of people with multi-drug resistant TB (MDR-TB) may die of their infection despite MDR treatment, which can be 10 to 50 times more expensive than that used for drug-sensitive TB. HIV/AIDS has also contributed to the resurgence of TB. One-quarter of the increase in TB incidence involves co-infection with HIV. TB is expected to rank second only to HIV/AIDS as a cause of infectious disease deaths by 2020.

From WHO Report 2005: Global Tuberculosis Control:

The WHO-recommended strategy for controlling TB is called DOTS (Directly Observed Therapy, Short Course).  Although labor-intensive, this method of case management by observing patients taking their drugs for at least the initial portion of the 6-8 month treatment period is very cost-effective, according to the World Bank.   Yet many national TB programs lack the skills and resources to implement effective DOTS programs, or they are overwhelmed by emerging problems such as multi-drug resistance.  Thus technical and financial assistance from developed nations is essential to control the current epidemic of TB. Although the vast majority of TB disease occurs in developing regions, the disease pattern in industrialized areas is changing due to immigration, travel and declining support for the public health infrastructure.

Coordinated TB control on a global level is a new strategy. The Stop TB Initiative, launched in November 1998 by WHO, has evolved into a broader Global Partnership to Stop TB. The Partnership involves numerous organizations and individuals committed to TB control worldwide.  Several coalitions of partners  have emerged to accelerate progress in specific areas, such as DOTS expansion, new TB drug development, and containment of MDR-TB emergencies.  In the words of Dr. Gro Harlem Brundtland, former Director-General of WHO, “We have a cure.  We need to mobilize the world to use it.”

See WHO's TB Fact Sheet at http://www.who.int/mediacentre/factsheets/fs104/en/

For more information on TB infection and disease, see the CDC website: www.cdc.gov/nchstp/tb

For more information on global TB control, see the Stop TB website: http://www.stoptb.org/